RedOrbit

Biotechnology Can Help Lessen The Effects Of Cow Farts RedOrbit The research team also tested a dairy biotechnology called rBST – a synthetic version of a cattle hormone that does not affect humans. Many dairy producers use rBST to help the cows produce more milk. The team injected one group of cattle with rBST and ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFnRhFmjwFvoxOjP9DmRt25iIOssQ&url=http://www.redorbit.com/news/science/1112889001/farts-from-cattle-less-smelly-with-biotech-070213/

Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) receives approval from ... NYSE Post Boston, MA, 07/05/2013 (nysepost) - Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) recently announced that it obtained approval from the Austin Health Human Research Ethics Committee to commence an open label study for the company's drug on ... Prana Biotechnology, Ltd. ADR (NASDAQ:PRAN) prospects broaden after ...Avauncer Drug Manufacturers Other Stocks Buzz: Allergan, Inc.(NYSE:AGN), DURECT ...Techsonian Prana obtains HREC approval for open-label extension study in Alzheimer's ...Pharmaceutical Business Review all 4 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGcYMhMe2Ag_btRrfI6MW1QhTCccA&url=http://nysepost.com/prana-biotechnology-limited-adr-nasdaqpran-receives-approval-from-the-austin-health-human-research-ethics-committee-2909

Biotechnology market poised to reach $414.5B in 2017, says report BioOptics World A new report from Transparency Market Research cites that the global biotechnology market was valued at $216.5 billion in 2011, and expects that it will reach $414.5 billion in 2017. Covering several market segments—including polymerase chain reaction ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE6gBrkHi6xxOre668T_Ob94Bcd_A&url=http://www.bioopticsworld.com/articles/2013/07/biotechnology-market-poised-to-reach-414-5b-in-2017-says-report.html

'Grinder' can listen to music player by wearing a loose wire coil around his neckDon't offer Rich Lee a pair of headphones to listen to music: he's already got a pair, even though you can't see them. They're implanted in his ears – a procedure carried out by a "body modification" expert.Now, by connecting his music player to a loose wire coil around his neck (which he can tuck under his shirt), Lee can listen to music without blocking out the outside world. The tiny magnets implanted invisibly in his outer ears pick up the signal and generate sound.But that's only the beginning. Lee, 34, who works as a salesman, intends to hook it up to an ultrasonic rangefinder – effectively giving himself bat-like echolocation. And he would like to have X-ray vision, super-strength, and anything else...

Source:
http://www.medworm.com/index.php?rid=7397462&cid=c_449_58_f&fid=36473&url=http%3A%2F%2Fwww.guardian.co.uk%2Ftechnology%2F2013%2Fjul%2F04%2Fheadphones-implanted-ear-grinder-rich-lee

California legislation to allow women
to be paid for their eggs for scientific research is sailing toward
final passage literally swaddled in motherhood and apple pie
arguments. Missing from the debate is a key reason behind
the bill – building profits for what some call the “baby
business.”

The legislation is touted as providing
equal treatment for women, permitting them to be paid for supplying
eggs for stem cell and other research, much as men are paid for
sperm. It also would put women who sell their eggs for research on an
equal economic footing with women who sell their eggs for fertility
treatments, which is currently permitted under state law. Payments to
those women range from an average of $9,000 to as much as $50,000,
according to a legislative analysis of the bill.

 Assemblywoman Susan Bonillla,
D-Concord, author of the bill(AB926), says,

“It is time to let women, just as any
other research subject, make an informed decision as to
participation, and justly compensate them for doing so.”

“It has led to a de facto prohibition
on women’s reproductive research in California, adversely
impacting the same women that the ban intended to protect. With few
oocytes donated, fertility research and fertility preservation
research has been at a standstill. This greatly affects women
suffering from fertility issues and women facing cancer who would
like to preserve their oocytes.”

“Unlike infertile women who are
considered patients, egg donors are treated as vendors( (her italics).
When they walk out of the IVF clinic, no one keeps track of them. 
My daughter’s death was not reported. The long-term risks of egg
donation are unknown."

“I fear that cases like mine are
buried deep by fertility centers concerned about their image. An
industry thriving on profits and reputation has little incentive to
report adverse events, or protect the health and medical rights of
donors.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/0ke5iLQwGdA/california-legislation-human-egg-sales.html

“Myriad did not create anything. To
be sure, it found an important and useful gene, but separating that
gene from its surrounding genetic material is not an act of
invention.”

"WARF did not create or alter the
properties inherent in stem cells any more than Myriad created or
altered the genetic information encoded in the DNA it claimed.” 

“We don't want to do anything that
gets in the way of finding treatments for some of the biggest killers
today, so we feel that all patients with all kinds of diseases
deserve to have access to these kinds of cells.”

"Human embryonic stem cells hold
great promise for advancing human health, and no one has the ethical
right to own them.”

 “The best course if WARF truly
cares about scientific advancement would be to
simply abandon these over-reaching patent claims.”

“A successful use of the Myriad case
as a precedent for throwing out the foundation’s patent would open
the door to similar challenges in just about any biotech product
using material derived from life.”

WARF made no immediate comment.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/LuLuZLLjyDo/challenge-to-warf-hesc-patents-cites.html

Stem Cell Therapy and Regenexx KUSA TV News

By: Regenexx

Link:
Stem Cell Therapy and Regenexx KUSA TV News - Video

Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma, Mumbai, India.
Improvement seen after Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. His neck and...

By: neurogenbsi

Read more from the original source:
Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma, Mumbai, India. - Video

Giving hope: The promise of stem cell therapy
MANILA - As stem cell treatment begins to gain traction among Filipinos, a surgeon believes the country is now entering a new phase in medicine.

By: TheABSCBNNews

Read more:
Giving hope: The promise of stem cell therapy - Video

Ars Technica

Old wheat, new genetic engineering may protect crop from deadly pest Ars Technica Currently, roughly 20 percent of humanity's caloric intake comes from wheat. Agricultural strains, specialized for bread or pasta production, have been bred for high productivity and resistance to many agricultural pests. But over the past few years ... Genes Found to Fight Wheat DiseasePayvand all 19 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG7K5YPhQJyd5nrF1b8ttI7E5j3fQ&url=http://arstechnica.com/science/2013/06/old-wheat-new-genetic-engineering-may-protect-crop-from-deadly-pest/

Puma Biotechnology to Join Russell 3000 Index EON: Enhanced Online News (press release) LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, is set to join the broad-market Russell 3000® Index following Russell Investments' annual reconstitution of its comprehensive set ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGMe0_2rZw7lw7hFvtUsOr_G311ZA&url=http://eon.businesswire.com/news/eon/20130624005273/en/Puma-Biotechnology/Alan-Auerbach/PB272

Prosensa Holding (RNA) IPO Opens Sharply Higher StreetInsider.com (subscription) Prosensa Holding is an innovative biotechnology company engaged in the discovery and development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company's primary focus is on rare ... Prosensa leaps in 1st day of Nasdaq tradingThe Idaho Statesman all 31 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFW63dhmZJa3SDxF7b7k92ytba9AA&url=http://www.streetinsider.com/Hot%2BIPOs/Prosensa%2BHolding%2B(RNA)%2BIPO%2BOpens%2BSharply%2BHigher/8459135.html

The Hindu

A joint campaign against GM crops, Biotechnology Bill The Hindu Cutting across party lines, several political leaders participated on Tuesday in a joint campaign with civil society groups and farmers' organisations against Genetically Modified crops and the Biotechnology Regulatory Authority of India (BRAI) Bill at ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEk_M5nOsbdxlmpuKqN-QK_K0o3aQ&url=http://www.thehindu.com/news/national/a-joint-campaign-against-gm-crops-biotechnology-bill/article4850719.ece

Biotechnology Recognized for contribution to renewable energy. ThomasNet Industrial News Room (press release) June 28, 2013 - BIO applauded President Barack Obama's recognition of contributions made by biotechnology to design of new biofuels and to agricultural productivity in the President's Climate Action Plan. BIO President and CEO Jim Greenwood ... BIO Applauds Legislation That Levels the Playing Field for Renewable ChemicalsThe Herald | HeraldOnline.com all 2 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHDkE5PDOeswb1T7b3r6kJQyY40sA&url=http://news.thomasnet.com/companystory/Biotechnology-Recognized-for-contribution-to-renewable-energy-20010655

Annual Shareholders' Meeting of Cytos Biotechnology Ltd: Shareholders ... PR Newswire (press release) Cytos Biotechnology Ltd (SIX:CYTN) today announced that its shareholders have approved all resolutions at the Annual Shareholders' Meeting 2013. The Annual Shareholders' Meeting of Cytos Biotechnology Ltd took place at the company's headquarters in ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHNhp77Ej9bOoymSHnlrLLTj0g84g&url=http://www.prnewswire.com/news-releases/annual-shareholders-meeting-of-cytos-biotechnology-ltd-shareholders-approve-all-resolutions-213537211.html

What Is Biotechnology Again? Motley Fool Understanding the ins and outs will come with time, but to get there investors need to grasp some of the basics. For instance: the difference between biotechnology and "traditional" pharmaceuticals. The two terms are often used (mistakenly ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNER4hiSmW9YZiM9aDFiH_nH4HDLLg&url=http://www.fool.com/investing/general/2013/06/26/what-is-biotechnology-again.aspx

Angelina Jolie, Medical College of Wisconsin and genome sequencing The Business Journal of Milwaukee (blog) Howard Jacob, director of the college's Human and Molecular Genetics Center, told me. “That's really where we want to spend our time. There are plenty of places out there that have more firepower in the research arena than we do.” Rich Kirchen is The ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGDVFSgZvMQQ7Be-XnApSrl6ZFWZA&url=http://www.bizjournals.com/milwaukee/blog/2013/06/angelina-jolie-the-medical-college-of.html

Targeted viral therapy destroys breast cancer stem cells in preclinical ... EurekAlert (press release) ... Endowed Chair in Cancer Research and co-leader of the Cancer Molecular Genetics program at VCU Massey, chairman of VCU School of Medicine's Department of Human and Molecular Genetics and director of the VCU Institute of Molecular Medicine. and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFQ0vIz5lE95WiRo0EgGPHOSJBHjg&url=http://www.eurekalert.org/pub_releases/2013-06/vcu-tvt062413.php

OICR congratulates Dr. Thomas J. Hudson on being named to the Order of ... Canada NewsWire (press release) In 2007, Dr. Hudson was appointed Professor in the Departments of Molecular Genetics and Medical Biophysics at the University of Toronto and he is a fellow of the Royal Society of Canada. He is editor-in-chief of the journal Human Genetics and has ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE7j84jrm2eBwg2yzfG7JNN6zi90w&url=http://www.newswire.ca/en/story/1192557/oicr-congratulates-dr-thomas-j-hudson-on-being-named-to-the-order-of-canada

AZoNano.com

RUSNANOPRIZE Award 2013 for Achievements in Nanomaterials and Surface ... AZoNano.com Professor Lukyanov also had a successful business in the field of molecular genetics, and a score of 40 in the Hirsch Index at the same time. Anatoly Chubays, the RUSNANO CEO, presents the RUSNANOPRIZE Award to Prof. Sergey Lukyanov at the 2012 ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFqopuDRiQ2dFMunyGxc14X2sgY6w&url=http://www.azonano.com/article.aspx?ArticleID%3D3536